A 20-year-old man from Southwest China was admitted to the outpatient Department of Dermatology with a 3-month history of proliferative plaque on his nose. The lesions began as pruritic papules that progressively ulcerated. Physical examination found one well-demarcated proliferative plaques with pustules and overlying yellow-brown crust (Fig. [1](#Fig1){ref-type="fig"}A). Before the eruption, no trauma or other clear source of infection was identified except for chronic scratching. The patient was otherwise healthy with no systemic symptoms or history of immunosuppression. All other serum chemistry values were within normal limits. The HIV antibody test was negative. Secretion bacterial culture was negative. The same white yeast-like colonies were obtained after 3 days with multi-point inoculation of skin tissue and secretions on SDA at 28 °C, and the fungus was identified empirically as *Prototheca* species due to being unicellular measuring \> 10 μm with endospores and without capsule. A skin biopsy was performed, and Gomori methenamine silver stains showed numerous round yeast cells without capsule invading skin and subcutaneous tissue, more easily visible within giant cells. Based on clinical and morphological characteristics of pathogens (Fig. [2](#Fig2){ref-type="fig"}), cutaneous protothecosis was initially diagnosed and systemic therapy with oral itraconazole 400 mg/day was started, and Rash relief was not obvious after 1 month of treatment. Taking into account that *Prototheca* species in general have low susceptibility to antimicrobial agents, and the lesions occurred on exposed areas similar as lupus, hydroxychloroquine sulfate 400 mg daily was first attempted to treat this rare infection, minocycline 100 mg/day was combined at the first 2 months, and the reduction of itraconazole was 200 mg per day for 2 months. Strikingly, the lesion improved after 1 month and completely resolved after 6 months (Fig. [1](#Fig1){ref-type="fig"}B). The lesions did not recur and no side effects appeared during 1 year of follow-up. Based on molecular sequencing, the fungus was identified as *Cryptococcus neoformans var. grubii*, and the final diagnosis was corrected as primary cutaneous cryptococcosis due to no clinical evidence of disseminated disease. The ITS nucleotide sequences were deposited in GenBank with accession number MT421896. We did misdiagnose the patient as cutaneous protothecosis initially due to our empirical morphological knowledge, but this special experience gave us the chance to re-examine the old drug, except for malaria parasite and spirochaete infections, and more potential antimicrobial activity of hydroxychloroquine sulfate should be further explored, such as antifungal or coronavirus activity.Fig. 1One well-demarcated proliferative plaques with pustules and overlying yellow-brown crust (**A**); resolution of lesions with atrophic superficial scar after 6-month treatment (**B**)Fig. 2Gomori methenamine silver stains showing numerous round yeast cells without capsule invading skin and subcutaneous tissue, more easily visible within giant cells. Scale bar 10 μm
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